November 01, 2025
The simulators market size is projected to expand from USD 14.72 billion in 2026 to USD 25.53 billion by 2034,...
Read MoreNovember 01, 2025
The anti-aging market size is expected to rise from USD 84.4 billion in 2026 to USD 129.88 billion by 2034, gr...
Read MoreNovember 26, 2025
The U.S. behavioral health market is anticipated to grow from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreNovember 13, 2025
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreNovember 07, 2025
According to market projections, the global generative AI in healthcare market, valued at USD 2.65 billion in 2025, is anticipated to reach USD 53.68 billion by 2035, growing at a CAGR of 35.10% over the next decade. Generative AI in healthcare enhances patient care, streamlines operations, and accelerates medical research. It helps doctors with di...
November 07, 2025
Market insights predict, the metagenomic sequencing industry is expected to grow from USD 2.24 billion in 2024 to USD 7.63 billion by 2034, driven by a CAGR of 13.04%. The rising prevalence of genetic and infectious disorders and the growing demand for biologics bolster market growth. North America led the global market owing to the availability of...
November 07, 2025
According to forecasts, the global PFAS testing market will grow from USD 469.61 million in 2024 to USD 1825.21 million by 2034, with an expected CAGR of 14.54%. Across the globe, the market is fueled by escalating awareness of PFAS's potential health effects, such as linked to different health issues. From this, North America dominated the market ...
November 07, 2025
Market insights predict the global diabetes management supplements industry will increase from USD 7.17 billion in 2025 to USD 17.7 billion by 2035, achieving a CAGR of 8.65%.The market is growing due to the increasing diabetes population and rising preference for natural blood sugar control products. North America dominates the market owing to hig...
November 07, 2025
According to market projections, the NUT midline carcinoma treatment sector is expected to grow from USD 23.92 billion in 2025 to USD 68.89 billion by 2035, reflecting a CAGR of 11.15%. The growth of the market is driven by innovations in targeted therapies, precision diagnostics, and increased global focus on rare oncologic indications. North Amer...
November 07, 2025
Projections indicate that, the global psoriatic arthritis treatment market will increase from USD 10.91 billion in 2025 to USD 26.76 billion by 2035, experiencing a CAGR of 9.44% over the next 10 years. The rising prevalence of psoriatic arthritis and the growing demand for biologics drive the market. North America dominated the global market due t...
November 07, 2025
Based on market forecasts, the global postpartum health supplements market, projected at USD 1.52 billion in 2025, is expected to reach USD 3.66 billion by 2035, growing at a CAGR of 9.14% over the forecast period. The postpartum health supplements market is growing due to increasing maternal health awareness. North America is leading due to its st...
November 06, 2025
According to market projections, the global bio-based propylene glycol market, valued at USD 289.25 million in 2024, is anticipated to reach USD 837.57 million by 2034, growing at a CAGR of 11.25% over the next decade. The growing new drug discovery research and the growing demand for natural excipients drive the global market. North America domina...
November 06, 2025
According to market projections, the life sciences BPO sector is expected to grow from USD 258 billion in 2024 to USD 895.54 billion by 2034, reflecting a CAGR of 13.64%. The life sciences BPO market is expanding due to increasing clinical trials as well as growing advancements in medical writing. North America led the market due to the presence of...
November 06, 2025
Market insights predict, the veterinary CRO and CDMO industry is expected to grow from USD 7.17 billion in 2024 to USD 16.13 billion by 2034, driven by a CAGR of 8.43%. The market is growing due to rising pet ownership and increased focus on animal health. Pharma companies are outsourcing R&D and manufacturing to reduce costs and speed up produ...